Overview
At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer. Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do. From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about RayzeBio: https://careers.bms.com/rayzebio/
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes. RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
We are seeking a **Radiopharmaceutical Medical Science Liaison** (RPT-MSL) for RayzeBio to be trusted agile partner to the Thought Leader community. The role will engage in authentic, peer-to-peer scientific dialogue with leading RPT Thought Leaders and HCPs to strengthen RayzeBio’s scientific leadership, accelerate patient impact and shape the future of care. Your insights will inform clinical strategy, evidence generation and launch, ensuring that our innovative medicines reach patients in need. Led by a successful and experienced team, RayzeBio aims to be the global leader in radiopharmaceuticals.
Key Responsibilities
- Build Scientific Partnerships: Facilitates scientific interactions and partnerships with Thought Leaders and HCPs including the multidisciplinary nuclear medicine team at top RPT institutions
- Liaise with institutions to understand clinical and RPT-unique levers and barriers to patient access in the context of clinical trials
- Lead high-impact scientific discussions and presentations that challenge conventional thinking and advance the standard of care. Educate on real-world evidence and clinical trial read-outs to key opinion leaders.
- Support clinical development: identify and recommend sites for trials, engage with investigators and site staff to educate on the trial and asset and identify barriers to enrollment. Deliver solutions that address the barriers and support enrollment.
- Gather Early, Actionable Insights: Conduct insight‐gathering sessions to uncover emerging clinical or diagnostic/imaging needs, treatment paradigms and barriers to optimal patient care. Translate frontline feedback into strategic recommendations
- Deliver Business-Critical Recommendations: Provide strategic input on trial designs and launch/brand /medical plan and materials. Advise or support payer discussions from a medical perspective.
- Real-Time Insight Synthesis: Rapidly onboard and distill external feedback to inform cross-functional teams (R&D, Medical, Commercial) on clinical strategy and lifecycle planning.
- Asset Advisory & Launch: Act as a scientific partner to medical and commercial/sales colleagues, guiding medical education and external engagement.
- Therapeutic Area Enablement: Educate internal stakeholders on evolving trends, real-world data and competitive landscape.
- Applies AI to improve team execution and decision‑making
Qualifications & Experience
- MD, PhD, PharmD (or equivalent) and/or closely related RPT specialty such as nuclear medicine technologist
- 7+ years of relevant experience in oncology and/or RPT with a minimum of 3 years of field experience with an RPT or solid tumor product
- Proven track record of external engagement with national and global Thought Leaders.
- Scientific agility: ability to engage in a peer-to-peer dialog about data in a fair and balanced way. Expert knowledge of clinical practice and evolving healthcare delivery models. Understands treatment paradigms and can frame information in a convincing way that resonates with physicians
- Customer/Commercial Mindset: results-oriented, positive, resilient attitude, able to quickly adapt in an ever-changing environment. Demonstrated ability to drive organizational performance. Experience identifying, engaging, and cultivating relationships with TLs and partnering with commercial/sales team.
- Teamwork/Enterprise Mindset: Ability to work independently and act as a team player by developing strong rapport and working relationships with external and internal stakeholders. Be a representative of RayzeBio in all interactions with external stakeholders. Holds a high level of integrity and good judgment, in order to navigate the requirements of the role effectively and compliantly in accordance with RayzeBio’s policies and procedures.
- Excellent communication and presentation skills to articulate scientific and clinical data in an easy-to-understand manner to help HCPs best serve their patients
- Has a strong learning mindset and passion for science. Prioritizes staying current with the latest data
- Willing to travel up to 50% of the time
